Minerva Neurosciences, Inc.
Pharmaceutical company · Burlington, Massachusetts, United States · Nasdaq: NERV
Minerva Neurosciences, Inc. is a pharmaceutical company headquartered in Burlington, Massachusetts, United States. Its shares trade on Nasdaq under the ticker NERV. It has reported private securities offerings to the US SEC, most recently $1 million sold in a notice filed in 2016.
Minerva Neurosciences at a glance
What does Minerva Neurosciences do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $1 million sold (2016).
Frequently asked questions about Minerva Neurosciences
Where is Minerva Neurosciences headquartered?
Minerva Neurosciences, Inc. is headquartered in Burlington, Massachusetts, United States.
What does Minerva Neurosciences do?
Minerva Neurosciences, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Minerva Neurosciences a public company?
Yes. Minerva Neurosciences, Inc. trades on Nasdaq under the ticker NERV.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.